![Douglas Love](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Love
Vorstandsvorsitzender bei
ANNEXON, INC.
Vermögen: 2 Mio $ am 31.05.2026
Profil
Douglas Love is President, Chief Executive Officer & Director at Annexon, Inc. since 2014.
Formerly, Mr. Love was Corporate Counsel at Amgen, Inc. from 1999 to 2001, Corporate Counsel at Genentech, Inc. from 2001 to 2006, Head-Operations & Strategic Alliances at Elan Pharmaceuticals LLC from 2008 to 2013, and Associate at Orrick Herrington & Sutcliffe LLP from 1996 to 1999.
Education includes an undergraduate degree from the University of Southern California in 1991 and a graduate degree from McGeorge School of Law in 1995.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ANNEXON, INC. 0.22% | 31.03.2026 | 356’133 ( 0.22% ) | 2 Mio $ | 31.05.2026 |
Aktive Positionen von Douglas Love
| Unternehmen | Position | Beginn |
|---|---|---|
| ANNEXON, INC. | Vorstandsvorsitzender | 01.12.2014 |
Ehemalige bekannte Positionen von Douglas Love
| Unternehmen | Position | Ende |
|---|---|---|
Elan Pharmaceuticals LLC
 Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Corporate Officer/Principal | 01.04.2013 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | General Counsel | 01.01.2006 |
| AMGEN INC. | General Counsel | 01.01.2001 |
Orrick Herrington & Sutcliffe LLP
 Orrick Herrington & Sutcliffe LLP Miscellaneous Commercial ServicesCommercial Services Operates as a law firm in technology, innovation, finance, energy and infrastructure sectors | Corporate Officer/Principal | 01.01.1999 |
Ausbildung von Douglas Love
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
91
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Elan Pharmaceuticals LLC
Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Annexon, Inc.
 Annexon, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurodegenerative and autoimmune disorders | Health Technology |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Orrick Herrington & Sutcliffe LLP
Orrick Herrington & Sutcliffe LLP Miscellaneous Commercial ServicesCommercial Services Operates as a law firm in technology, innovation, finance, energy and infrastructure sectors | Commercial Services |
Mcgeorge School of Law
 Mcgeorge School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
